Cough in chronic obstructive pulmonary disease: is it important and what are the effects of treatment?

Por Calverley, Peter MA
Publicado em 2013

Integrating COPD care in Italy

Por Calverley, Peter MA
Publicado em 2014

Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease

Por Chakrabarti, Biswajit, Calverley, Peter MA, Davies, Peter DO
Publicado em 2007

Roflumilast: a review of its use in the treatment of COPD

Por Wedzicha, Jadwiga A, Calverley, Peter MA, Rabe, Klaus F
Publicado no Int J Chron Obstruct Pulmon Dis (2016)

Chronic obstructive pulmonary disease and exacerbations: Patient insights from the global Hidden Depths of COPD survey

Por Barnes, Neil, Calverley, Peter MA, Kaplan, Alan, Rabe, Klaus F
Publicado em 2013

Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD

Por Goehring Udo M, Calverley Peter MA, Rennard Stephen I, Bredenbröker Dirk, Martinez Fernando J
Publicado em 2011-01-01

The severity of airways obstruction as a determinant of treatment response in COPD

Por Calverley, Peter MA, Pauwels, Romain A, Jones, Paul W, Anderson, Julie A, Vestbo, Jørgen
Publicado em 2006

Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD

Por Rennard, Stephen I, Calverley, Peter MA, Goehring, Udo M, Bredenbröker, Dirk, Martinez, Fernando J
Publicado em 2011

Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol

Por Calverley, Peter MA, Martinez, Fernando J, Fabbri, Leonardo M, Goehring, Udo-Michael, Rabe, Klaus F
Publicado em 2012

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease

Por Calverley, Peter MA, Rennard, Stephen, Nelson, Harold S, Karpel, Jill P, Abbate, Eduardo H, Stryszak, Paul, Staudinger, Heribert
Publicado em 2008

Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial

Por Wise, Robert, Calverley, Peter MA, Dahl, Ronald, Dusser, Daniel, Metzdorf, Norbert, Müller, Achim, Fowler, Andy, Anzueto, Antonio
Publicado no NPJ Prim Care Respir Med (2015)

Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease

Por Rodriguez-Roisin, Roberto, Tetzlaff, Kay, Watz, Henrik, Wouters, Emiel FM, Disse, Bernd, Finnigan, Helen, Magnussen, Helgo, Calverley, Peter MA
Publicado no Int J Chron Obstruct Pulmon Dis (2016)

The association of tidal EFL with exercise performance, exacerbations, and death in COPD

Por Aarli, Bernt Boegvald, Calverley, Peter MA, Jensen, Robert L, Dellacà, Raffaele, Eagan, Tomas ML, Bakke, Per S, Hardie, Jon A
Publicado no Int J Chron Obstruct Pulmon Dis (2017)

Factors associated with change in exacerbation frequency in COPD

Por Donaldson, Gavin C, Müllerova, Hanna, Locantore, Nicholas, Hurst, John R, Calverley, Peter MA, Vestbo, Jorgen, Anzueto, Antonio, Wedzicha, Jadwiga A
Publicado em 2013

Chronic airflow limitation in a rural Indian population: etiology and relationship to body mass index

Por Chakrabarti, Biswajit, Purkait, Sabita, Gun, Punyabrata, Moore, Vicky C, Choudhuri, Samadrita, Zaman, MJ, Warburton, Christopher J, Calverley, Peter MA, Mukherjee, Rahul
Publicado em 2011

Development and the initial validation of a new self-administered questionnaire for an early detection of health status changes in smokers at risk for chronic obstructive pulmonary...

Por Vrbica, Žarko, Labor, Marina, Košćec Đuknić, Adrijana, Radošević-Vidaček, Biserka, Gudelj, Ivan, Labor, Slavica, Jurić, Iva, Calverley, Peter MA, Plavec, Davor
Publicado no Croat Med J (2016)

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

Por Jenkins, Christine R, Jones, Paul W, Calverley, Peter MA, Celli, Bartolome, Anderson, Julie A, Ferguson, Gary T, Yates, Julie C, Willits, Lisa R, Vestbo, Jörgen
Publicado em 2009

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change

Por Jones, Paul W, Anderson, Julie A, Calverley, Peter MA, Celli, Bartolome R, Ferguson, Gary T, Jenkins, Christine, Yates, Julie C, Vestbo, Jørgen, Spencer, Michael D
Publicado em 2011

Characterisation of COPD heterogeneity in the ECLIPSE cohort

Por Agusti Alvar, Calverley Peter MA, Celli Bartolome, Coxson Harvey O, Edwards Lisa D, Lomas David A, MacNee William, Miller Bruce E, Rennard Steve, Silverman Edwin K, Tal-Singer Ruth, Wouters Emiel, Yates Julie C, Vestbo Jørgen
Publicado em 2010-09-01

Characterisation of COPD heterogeneity in the ECLIPSE cohort

Por Agusti, Alvar, Calverley, Peter MA, Celli, Bartolome, Coxson, Harvey O, Edwards, Lisa D, Lomas, David A, MacNee, William, Miller, Bruce E, Rennard, Steve, Silverman, Edwin K, Tal-Singer, Ruth, Wouters, Emiel, Yates, Julie C, Vestbo, Jørgen
Publicado em 2010